GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangxi Xinganjiang Pharmaceutical Co Ltd (BJSE:873167) » Definitions » Interest Income

Jiangxi Xinganjiang Pharmaceutical Co (BJSE:873167) Interest Income : ¥2.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Jiangxi Xinganjiang Pharmaceutical Co Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Jiangxi Xinganjiang Pharmaceutical Co's interest income for the three months ended in Dec. 2024 was ¥0.3 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2024 was ¥2.0 Mil.

Jiangxi Xinganjiang Pharmaceutical Co Interest Income Historical Data

The historical data trend for Jiangxi Xinganjiang Pharmaceutical Co's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Xinganjiang Pharmaceutical Co Interest Income Chart

Jiangxi Xinganjiang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Income
Get a 7-Day Free Trial Premium Member Only 0.15 0.14 0.17 1.54 1.96

Jiangxi Xinganjiang Pharmaceutical Co Quarterly Data
Sep19 Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.57 0.36 0.68 0.35

Jiangxi Xinganjiang Pharmaceutical Co Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangxi Xinganjiang Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangxi Xinganjiang Pharmaceutical Co Ltd (BJSE:873167) » Definitions » Interest Income
Comparable Companies
SHSE:603139 BJSE:836433 BJSE:832566 SZSE:300391 BJSE:833230 SHSE:600381 SZSE:301075 SZSE:002826 SZSE:002817 SZSE:301130 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 36 Yunzhang Road, Jizhou District, Jiangxi Province, Ji'an City, CHN, 343000
Website
http://www.xgjyy.com
Jiangxi Xinganjiang Pharmaceutical Co Ltd research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, Phenaminokamin Tablets.

Jiangxi Xinganjiang Pharmaceutical Co Headlines

No Headlines